Categories
Connect with us on LinkedIn
Patients as Partners EU 2022: How hybrid trials can further reduce patient burden
Join thought leaders in clinical research including Castor's own Kimberly Tableman as they discuss reducing patient burden in...
Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials
Castor announces the launch of its CRO Partnership program designed to increase adoption of decentralized clinical trials and...
Executive interview with Derk Arts at Fierce JPM Week 2022
Watch this webinar for pandemic lessons the healthcare industry learned that can help tackle longtime challenges in clinical...
DTx Clinical Trials and Data Standardization
In this paper, Castor explores the benefits and challenges of Digital Therapeutics (DTx) trials and provides recommendations on...
Bridging clinical efficacy and real-world effectiveness in digital therapeutics trials
Tech tools help Digital Therapeutics (DTx) maximize the impact of the real-world data they capture, explore how in...
Choosing Your Best Route to DTx Commercialization
In this guide, Castor discusses routes to digital therapeutics commercialization and tools to meet the challenges on the...
Navigating the DTx Regulatory Landscape
The regulations around digital therapeutics (DTx) are constantly changing. Learn how DTx providers are trying to overcome these...
Effortless hybrid consent with Castor eConsent
Designed for decentralized, hybrid, and traditional research projects, Castor’s eConsent solution delivers compliant, site-friendly & participant-centric trial onboarding...
Today’s Challenges for Digital Therapeutics
Digital Therapeutics (DTx) is a rapidly growing space whose players are facing challenges in scaling their businesses, including...
Regulating Digital Therapeutic Cybersecurity: Today and Tomorrow
Cybersecurity has become a concern for Digital Therapeutics (DTx) developers and regulatory bodies. Learn to balance functionality &...
Castor Delivers Strong Finish to 2021, Continues Expansion into US Market
Castor announced transformative growth with anticipated topline acceleration driven by the company’s momentous US market expansion
Castor named to the 2021 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups
CB Insights named Castor to its third annual Digital Health 150, which showcases the 150 most promising private...
Getting Started with DCT in 2022
Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these...
How to Incorporate Remote Technology in Your Next Medical Device Trial
Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications....
Overview of EU Medical Device Regulations
Medical device regulations in the EU have recently undergone a major overhaul. Learn the key tenets of MDR...
Castor Appoints Digital Leader Milind Kamkolkar to Board of Directors
Industry veteran Milind Kamkolkar joins Castor’s Board of Directors to advance mission of democratizing clinical research by maximizing...
How Medical Device Trials Can Benefit From Decentralized Methods
In this whitepaper, we will look at how EDC, eConsent, ePRO, and APIs enable researchers to easily conduct...
Castor is accelerating global medical device research with decentralized clinical trials platform
Castor’s DCT platform helping medical device trials achieve compliance with patient-focused technology Driving innovation for medical device clinical...